In the HF context, activation of the renin-angiotensin II-aldosterone system (RAAS) has a well-documented detrimental role, and blockade of RAAS can significantly reduce morbidity and mortality25 although the outcome of HF patients remains extremely poor even in the presence of optimal medical therapy that includes RAAS blockers26. This evidence concerns the gene AGT and hydrops fetalis.